1
|
Wu X, Heller M, Lokken R, Fidelman N, Lam A. Abstract No. 264 Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score Adjusted Analysis. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023] Open
|
2
|
Lam A, Jankovic L, Aharonyan L, McGroarty K, Prince M, Morris L, Stang C, Berdahl C, Torbati S. 95 A Tender-Loving-Care Volunteer Program to Provide Non-Clinical, Supportive Interventions to Older Adults in the Emergency Department. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
3
|
Gorantla V, Heller M, Wu X, Lam A. Abstract No. 224 Comparison of outcomes in patients with biliary obstruction undergoing endoscopic retrograde cholangiopancreatography with biliary stenting versus percutaneous transhepatic biliary drainage. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
4
|
Zhou A, Wu X, Youm J, Heller M, Lam A. Abstract No. 203 Drug-coated balloon angioplasty versus conventional balloon angioplasty for arteriovenous fistula stenosis: a cost effectiveness study. J Vasc Interv Radiol 2022. [DOI: 10.1016/j.jvir.2022.03.284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
5
|
Tanner H, Goulouti E, Lam A, Elchinova E, Nozica N, Servatius H, Noti F, Seiler J, Baldinger SH, Haeberlin A, Franzeck F, Asatryan B, Reichlin T, Roten L. Gender gap in study inclusion: Insights from the STAR-FIB cohort study. Europace 2022. [DOI: 10.1093/europace/euac053.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): Swiss National Science Foundation Swiss Heart Foundation
Background
The underrepresentation of women in cardiovascular clinical trials is well described but cannot be fully explained by sex-specific differences in the prevalence of cardiovascular diseases. Data on potential sex- and gender-related differences in study exclusion reasons are scarce.
The STAR-FIB cohort study aimed to estimate the age and sex-specific prevalence of screening-detected atrial fibrillation (AF) in 800 hospitalized patients aged 65-84 years using serial seven-day ECGs. Recruitment for study inclusion was stratified by sex (female/male, as stated in the patient’s records) and age (four age bands, ≥65 to <70, ≥70 to <75, ≥75 to <80, and ≥80 to <85 years), and was truncated for each subgroup after the inclusion of 100 participants.
Purpose
To assess sex and gender differences in patient recruitment for inclusion in the STAR-FIB cohort study.
Methods
A screening log containing sex-category, age, and reasons for exclusion was maintained. Exclusion criteria are shown in the figure. For the purpose of the present study, an explorative analysis of all exclusion criteria with respect to sex category was done.
Results
Overall, 11’470 patients were identified for eligibility, 795 patients (49% women; mean age 75 years) were enrolled, and 10’675 patients (52% women vs. 48% men, p =0.13) were not enrolled. The two major exclusion reasons were unwillingness to participate, which was more frequent in women (27.9% of women vs. 18.4% of men, p < 0.01), and the presence of clinical AF, which was more prevalent in men (27.1% of men vs. 20.5 % of women, p < 0.01). A detailed analysis of all exclusion criteria analysed by sex category is provided in the figure.
Conclusions
Clinical AF was more frequent in men, in accordance with the well described sex-driven (biological) higher prevalence of AF in men. In contrast, we found a higher percentage of women unwilling to participate in this study, which may represent a more gender-based (sociocultural) phenomenon. A further exploration of these findings should be performed and may help to identify and potentially overcome modifiable obstacles for study participation.
Collapse
Affiliation(s)
- H Tanner
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - E Goulouti
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - A Lam
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - E Elchinova
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - N Nozica
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - H Servatius
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - F Noti
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - J Seiler
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - SH Baldinger
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - A Haeberlin
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - F Franzeck
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - B Asatryan
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - T Reichlin
- Bern University Hospital, Cardiology, Bern, Switzerland
| | - L Roten
- Bern University Hospital, Cardiology, Bern, Switzerland
| |
Collapse
|
6
|
Goulouti E, Lam A, Nozica N, Elchinova E, Spirito A, Servatius H, Noti F, Seiler J, Baldinger S, Haeberlin A, Babken A, Franzeck F, Tanner H, Reichlin T, Roten L. Incidental arrhythmias during atrial fibrillation screening in a hospital-based patient population. Europace 2022. [DOI: 10.1093/europace/euac053.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Screening for atrial fibrillation may reveal other, incidental arrhythmias of relevance. We sought to describe such incidental arrhythmias in the prospective STARFIB cohort study, which screened for silent atrial fibrillation in hospitalized patients aged 65-84 years.
Method
Patients included in the STARFIB cohort study had up to three 7-day Holter ECGs, performed in two-month intervals. We analysed all the 7-day Holter ECGs of study participants for the presence of one of the following incidental arrhythmias: 1) sick-sinus-syndrome (SSS), defined as sinus arrest of ≥3 seconds duration; 2) second or higher degree atrioventricular block (AVB); 3) sustained atrial tachycardia of ≥30 seconds duration (AT); and 4) sustained ventricular tachycardia of ≥30 seconds duration (VT).
Results
A total of 2’077 Holter ECGs were performed in 794 patients (mean age 74.7 years; 49% females), resulting in a mean cumulative duration of an analyzable ECG signal of 414±136 hours per patient. We found incidental arrhythmias in 94 patients (11.8%). Among these were SSS in 14 patients (1.8%), AVB in 41 (5.2%), AT in 41 (5.2%), and VT in two (0.3%). The median pause duration in SSS was 4 seconds and SSS resulted in pacemaker implantation in one patient with a pause of 9 seconds duration. The most severe type of AVB found per patient was second degree AVB type Wenkebach in 23 patients (2.9%), second degree AVB type Mobitz or 2:1 AV conduction in 10 patients (1.3%) and complete AVB in 8 (1%; maximum pause 18 seconds). AVB led to pacemaker implantation in 9 patients (1.1%). The median duration and heart rate of AT was 2.2 minutes and 144 bpm, respectively. Initiation of betablocker therapy was recommended in 3 patients (0.4%) due to symptomatic AT. The duration and heart rate of VT was 3 minutes at 216 bpm in one patient and 38 seconds at 150 bpm in another. The former patient with VT experienced syncope and an ICD was implanted, whereas in the latter the betablocker dose was increased. One patient died from a non-cardiac cause during a Holter ECG, which showed progressive bradycardia and finally asystole.
Conclusion
Incidental arrhythmias were frequently discovered during screening for atrial fibrillation and resulted in device therapy in 1.4% of our cohort patients.
Collapse
Affiliation(s)
- E Goulouti
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - A Lam
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - N Nozica
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - E Elchinova
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - A Spirito
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - H Servatius
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - F Noti
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - J Seiler
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - S Baldinger
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - A Haeberlin
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - A Babken
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - F Franzeck
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - H Tanner
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - T Reichlin
- Bern University Hospital, Inselspital, Bern, Switzerland
| | - L Roten
- Bern University Hospital, Inselspital, Bern, Switzerland
| |
Collapse
|
7
|
Vassilev S, Sue Y, Lim Z, Sivalingam J, Lam A, Ho V, Renia L, Malleret B, Reuveny S, Oh S. iPSC: SELECTION OF O-VE IPSC CLONES FOR HIGH-DENSITY RED BLOOD CELL PRODUCTION IN A SCALABLE PERFUSION BIOREACTOR SYSTEM. Cytotherapy 2022. [DOI: 10.1016/s1465-3249(22)00390-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
8
|
Pride T, Lam A, Swansburg J, Seno M, Lowe MB, Bomfim E, Toombs E, Marsan S, LoRusso J, Roy J, Gurr E, LaFontaine J, Paul J, Burack JA, Mushquash C, Stewart SH, Wendt DC. Trauma-informed Approaches to Substance Use Interventions with Indigenous Peoples: A Scoping Review. J Psychoactive Drugs 2021; 53:460-473. [PMID: 34895091 DOI: 10.1080/02791072.2021.1992047] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Indigenous Peoples experience disproportionately higher rates of problematic substance use. These problems are situated in a context of individual and intergenerational trauma from colonization, residential schools, and racist and discriminatory practices, policies, and services. Therefore, substance use interventions need to adopt a trauma-informed approach. We aimed to synthesize and report the current literature exploring the intersection of trauma and substance use interventions for Indigenous Peoples. Fourteen databases were searched using keywords for Indigenous Peoples, trauma, and substance use. Of the 1373 sources identified, 117 met inclusion criteria. Literature on trauma and substance use with Indigenous Peoples has increased in the last 5 years (2012-2016, n = 29; 2017-2021, n = 48), with most literature coming from the United States and Canada and focusing on historical or intergenerational trauma. Few articles focused on intersectional identities such as 2SLGBTQIA+ (n = 4), and none focused on veterans. There were limited sources (n = 25) that reported specific interventions at the intersection of trauma and substance use. These sources advocate for multi-faceted, trauma-informed, and culturally safe interventions for use with Indigenous Peoples. This scoping review illuminates gaps in the literature and highlights a need for research reporting on trauma-informed interventions for substance use with Indigenous Peoples.
Collapse
Affiliation(s)
- T Pride
- Faculty of Health, Dalhousie University, Halifax, Canada
| | - A Lam
- Centre de Recherche du Chum, Université de Montréal, Montreal, Canada
| | - J Swansburg
- Centre de Recherche du Chum, Université de Montréal, Montreal, Canada.,Psychology and Neuroscience, Dalhousie University, Halifax, Canada
| | - M Seno
- Centre de Recherche du Chum, Université de Montréal, Montreal, Canada.,Psychology and Neuroscience, Dalhousie University, Halifax, Canada.,Maastricht University, Psychology and Neuroscience, Maastricht, The Netherlands
| | - M B Lowe
- Health and Human Performance, Dalhousie University, Halifax, Canada
| | - E Bomfim
- Educational and Counselling Psychology, McGill University, Montreal, Canada.,Psychology, Concordia University, Montreal, Canada
| | - E Toombs
- Psychology, Lakehead University, Thunder Bay, Canada
| | - S Marsan
- Family and Emergency Medicine, Université de Montréal, Montreal, Canada
| | - J LoRusso
- Psychology and Neuroscience, Dalhousie University, Halifax, Canada
| | - J Roy
- Social Work, McGill University, Montreal, Canada
| | - E Gurr
- Educational and Counselling Psychology, McGill University, Montreal, Canada
| | - J LaFontaine
- Integrated Studies in Education, McGill University, Montreal, Canada
| | - J Paul
- Psychology and Neuroscience, Dalhousie University, Halifax, Canada
| | - J A Burack
- Educational and Counselling Psychology, McGill University, Montreal, Canada
| | - C Mushquash
- Psychology, Lakehead University, Thunder Bay, Canada
| | - S H Stewart
- Psychology and Neuroscience, Dalhousie University, Halifax, Canada.,Psychiatry, Dalhousie University, Halifax, Canada
| | - D C Wendt
- Educational and Counselling Psychology, McGill University, Montreal, Canada
| |
Collapse
|
9
|
Wittmer S, Chollet L, Baldinger S, Servatius H, Seiler J, Madaffari A, Kueffer T, Muehl A, Asatryan B, Lam A, Noti F, Haeberlin A, Roten L, Tanner H, Reichlin T. Impact of clinical risk factor profile vs. atrial fibrillation phenotype on outcome after pulmonary vein isolation. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Aims
Catheter ablation for atrial fibrillation (AF) is increasingly performed. Both clinical risk factors as well as the AF phenotype have been shown to influence ablation outcomes. The inter-relationship of the two however is incompletely understood.
Methods
In a retrospective analysis of a prospective registry of patients undergoing a first pulmonary vein isolation, the association of 8 predefined clinical risk factors (age >70 years, female gender, hypertension, BMI >30 kg/m2, coronary artery disease, heart failure, chronic kidney disease (CKD; eGFR<60ml/min/1.73m2) and diabetes mellitus) and the AF phenotype (paroxysmal vs. persistent AF) were assessed as well as their impact on AF recurrence during follow-up.
Results
Overall, 715 patients were enrolled (median age 63 years, 27% females, 69% paroxysmal AF). The prevalence of obesity, hypertension, heart failure and CKD was significantly higher in persistent AF, while female gender was more prevalent in paroxysmal AF. After 2 years of follow-up, overall freedom from recurrence was 46%, and was higher in paroxysmal AF compared to persistent AF (54.1% vs. 29.1%, p<0.001). Of the clinical risk factors, obesity (p=0.02), CKD (p=0.01) and heart failure (p=0.01) were significantly associated with lower arrhythmia-free survival, and there was a trend for hypertension and coronary artery disease (both p<0.2). A risk score composed of those 5 factors was associated with recurrences in patients with paroxysmal AF (p=0.04, Figure 1), but not in those with persistent AF (p=0.85, Figure 2).
Conclusion
Clinical risk factors predict outcome after pulmonary vein isolation in patients with paroxysmal, but not persistent AF. This is likely due to a strong association of those risk factors with the occurrence of persistent AF.
Funding Acknowledgement
Type of funding sources: None. Figure 1Figure 2
Collapse
Affiliation(s)
- S Wittmer
- Inselspital - University of Bern, Bern, Switzerland
| | - L Chollet
- Inselspital - University of Bern, Bern, Switzerland
| | - S Baldinger
- Inselspital - University of Bern, Bern, Switzerland
| | - H Servatius
- Inselspital - University of Bern, Bern, Switzerland
| | - J Seiler
- Inselspital - University of Bern, Bern, Switzerland
| | - A Madaffari
- Inselspital - University of Bern, Bern, Switzerland
| | - T Kueffer
- Inselspital - University of Bern, Bern, Switzerland
| | - A Muehl
- Inselspital - University of Bern, Bern, Switzerland
| | - B Asatryan
- Inselspital - University of Bern, Bern, Switzerland
| | - A Lam
- Inselspital - University of Bern, Bern, Switzerland
| | - F Noti
- Inselspital - University of Bern, Bern, Switzerland
| | - A Haeberlin
- Inselspital - University of Bern, Bern, Switzerland
| | - L Roten
- Inselspital - University of Bern, Bern, Switzerland
| | - H Tanner
- Inselspital - University of Bern, Bern, Switzerland
| | - T Reichlin
- Inselspital - University of Bern, Bern, Switzerland
| |
Collapse
|
10
|
Goodman S, Bagai A, Tan M, Andrade J, Spindler C, Malek-Marzban P, Har B, Yip A, Paniagua M, Elbarouni B, Bainey K, Paradis J, Maranda R, Cantor W, Doucet M, Khan R, Eisenberg M, Dery J, Schwalm J, Madan M, Lam A, Hameed A, Noronha L, Cieza T, Matteau A, Roth S, So D, Lavi S, Glanz A, Gao D, Tahiliani R, Welsh R, Kim H, Robinson S, Daneault B, Chong A, Le May M, Ahooja V, Gregoire J, Nadeau P, Laksman Z, Heilbron B, Bonakdar H, Yung D, Yan A. ANTITHROMBOTIC THERAPIES IN CANADIAN ATRIAL FIBRILLATION PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEASE: INSIGHTS FROM THE CONNECT AF+PCI-I AND -II PROGRAMS. Can J Cardiol 2021. [DOI: 10.1016/j.cjca.2021.07.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
11
|
Oh S, Lam A, Sivalingam J, Lim Z, Loh Y, Reuveny S, Malleret B. Generation of high densities of universal O-ve red blood cells from human induced pluripotent stem cells in bioreactors. Cytotherapy 2021. [DOI: 10.1016/s1465324921002760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Lam A, Jayaraman P, Tong G, Ho V, Reuveny S, Oh S. Directed differentiation of pluripotent stem cells toward retinal pigment epithelium lineage by crispr activation. Cytotherapy 2021. [DOI: 10.1016/s1465324921004758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
13
|
Martin B, Seguin J, Annereau M, Fleury T, Lai-Kuen R, Neri G, Lam A, Bally M, Mignet N, Corvis Y. Preparation of parenteral nanocrystal suspensions of etoposide from the excipient free dry state of the drug to enhance in vivo antitumoral properties. Sci Rep 2020; 10:18059. [PMID: 33093456 PMCID: PMC7581827 DOI: 10.1038/s41598-020-74809-z] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Accepted: 10/05/2020] [Indexed: 12/18/2022] Open
Abstract
Nanoparticle technology in cancer chemotherapy is a promising approach to enhance active ingredient pharmacology and pharmacodynamics. Indeed, drug nanoparticles display various assets such as extended blood lifespan, high drug loading and reduced cytotoxicity leading to better drug compliance. In this context, organic nanocrystal suspensions for pharmaceutical use have been developed in the past ten years. Nanocrystals offer new possibilities by combining the nanoformulation features with the properties of solid dispersed therapeutic ingredients including (i) high loading of the active ingredient, (ii) its bioavailability improvement, and (iii) reduced drug systemic cytotoxicity. However, surprisingly, no antitumoral drug has been marketed as a nanocrystal suspension until now. Etoposide, which is largely used as an anti-cancerous agent against testicular, ovarian, small cell lung, colon and breast cancer in its liquid dosage form, has been selected to develop injectable nanocrystal suspensions designed to be transferred to the clinic. The aim of the present work is to provide optimized formulations for nanostructured etoposide solutions and validate by means of in vitro and in vivo evaluations the efficiency of this multiphase system. Indeed, the etoposide formulated as a nanosuspension by a bottom-up approach showed higher blood life span, reduced tumor growth and higher tolerance in a murine carcinoma cancer model. The results obtained are promising for future clinical evaluation of these etoposide nanosuspensions.
Collapse
Affiliation(s)
- Brice Martin
- Université de Paris, CNRS, Inserm, UTCBS, Chemical and Biological Technologies for Health Group (utcbs.cnrs.fr), Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006, Paris, France.,Department of Neurological Surgery, Weill Medical College of Cornell University, New York, NY, USA
| | - Johanne Seguin
- Université de Paris, CNRS, Inserm, UTCBS, Chemical and Biological Technologies for Health Group (utcbs.cnrs.fr), Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006, Paris, France
| | - Maxime Annereau
- Gustave Roussy, 114 rue Edouard Vaillant, 94800, PharmacyVillejuif, France
| | - Thomas Fleury
- Gustave Roussy, 114 rue Edouard Vaillant, 94800, PharmacyVillejuif, France
| | - René Lai-Kuen
- Université de Paris, CNRS, Inserm, Cellular and Molecular Imaging Technology Platform, Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006, Paris, France
| | - Giovanni Neri
- Université de Paris, CNRS, Inserm, UTCBS, Chemical and Biological Technologies for Health Group (utcbs.cnrs.fr), Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006, Paris, France
| | - Anita Lam
- Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, BC, V6T 1Z1, Canada
| | - Marcel Bally
- Department of Experimental Therapeutics, British Columbia Cancer Research Centre, Vancouver, BC, V5Z 1L3, Canada
| | - Nathalie Mignet
- Université de Paris, CNRS, Inserm, UTCBS, Chemical and Biological Technologies for Health Group (utcbs.cnrs.fr), Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006, Paris, France
| | - Yohann Corvis
- Université de Paris, CNRS, Inserm, UTCBS, Chemical and Biological Technologies for Health Group (utcbs.cnrs.fr), Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006, Paris, France.
| |
Collapse
|
14
|
Raab S, Roten L, Branca M, Nozica N, Wilhelm M, De Marchi S, Brugger N, Elchinova E, Seiler J, Asatryan B, Tanner H, Baldinger SH, Lam A, Reichlin T, Servatius H. P311Hypertrophic cardiomyopathy and other forms of left ventricular hypertrophy. The P wave can make the difference. Europace 2020. [DOI: 10.1093/europace/euaa162.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Structural disarray of hypertrophied myocytes and interstitial fibrosis characterize hypertrophic cardiomyopathy (HCM). These morphological changes also affect atrial myocytes and, together with hemodynamic alterations because of HCM, may lead to atrial cardiomyopathy.
Purpose
To investigate the incremental value of P-wave parameters to differentiate left ventricular hypertrophy (LVH) because of HCM from LVH in hypertensive heart disease (HHD) and athletes heart.
Methods
In a prospective study, we compared electrocardiographic (including signal-averaged ECG of the P wave) and echocardiographic data of patients with HCM, HHD and athletes heart. We developed a predictive model with a simple scoring system to identify HCM.
Results
We compared data of 27 patients with HCM (70% males, 49.8 ± 14.5 years), 324 patients with HHD (52% males, 74.8 ± 5.5 years), and 215 subjects with athletes heart (72% males, 42.3 ± 7.5). The table shows the significant differences among the 3 groups. We included the following parameters into a predictive score to differentiate HCM from other forms of LVH: QRS width (>88ms = 1 point), P-wave integral (>688µVs = 1 point) and septum thickness (>12mm = 2 points). A score >2 (Youden index 0.626) correctly classified HCM in 81% of the cases with a sensitivity and specificity of 82% an 81%, respectively.
Conclusion Differentiation of HCM from other forms of LVH is improved by including atrial parameters. A simple scoring system including septum thickness, QRS width and P wave integral allowed identification of patients with HCM with a sensitivity and specificity of >80%. This score needs to be validated prospectively.
Table 1 HCM HHD Athletes P-value HCM vs HHD* HCM vs Athletes* 95%-CI P-value 95%-CI P-value P-wave duration [ms] 152.7 ± 25.8 143.9 ± 16.5 133.5 ± 14.2 <0.001 -16.9 -24.6 to -9.1 <0.001 -16.3 -22.7 to -9.9 <0.001 P-wave integral [µVs] 850.4 ± 272.4 672.0 ± 235.4 773.1 ± 260.1 <0.001 -198.6 -320.8 to -76.3 0.002 -68.2 -169.7 to 33.2 0.187 QRS [ms] 110.3 ± 27.3 96.9 ± 20.3 95.1 ± 9.8 <0.001 -16.4 -24.7 to -8.1 <0.001 -13.8 -20.8 to -6.9 <0.001 QTc [ms] 447.9 ± 27.2 438.6 ± 24.5 414.0 ± 22.9 <0.001 -21.1 -32.7 to -9.5 <0.001 -30.8 -40.5 to -21.2 <0.001 LVMMI [g/m2] 153.6 ± 55.5 133.5 ± 30.3 98.6 ± 19.7 <0.001 -15.3 -29.7 to -0.9 0.038 -56.1 -67.7 to -44.6 <0.001 IVS [ms] 16.8 ± 4.2 11.8 ± 2.2 10.3 ± 1.5 <0.001 -5.2 -6.3 to -4.1 <0.001 -6.4 -7.3 to -5.6 <0.001 LAVI [ml/m2] 43.2 ± 13.9 30.5 ± 9.7 30.8 ± 9.5 <0.001 -14.6 -20.0 to -9.3 <0.001 -12.2 -16.6 to -7.9 <0.001 The table shows the study result after univariate and multivariate (*; adjusting for age and sex) analysis.
Abstract Figure 1
Collapse
Affiliation(s)
- S Raab
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - L Roten
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - M Branca
- CTU Bern, University of Bern, Bern, Switzerland
| | - N Nozica
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - M Wilhelm
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - S De Marchi
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - N Brugger
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - E Elchinova
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - J Seiler
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - B Asatryan
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - H Tanner
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - S H Baldinger
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - A Lam
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - T Reichlin
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - H Servatius
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| |
Collapse
|
15
|
Maurhofer J, Tanner H, Haeberlin A, Noti F, Seiler J, Baldinger SH, Roten L, Lam A, Asatryan B, Nozica N, Franzeck F, Kueffer T, Reichlin T, Servatius H. P1492Comparison of the long-term performance of the quadripolar IS-4 and the bipolar IS-1 left ventricular lead for cardiac resynchronization therapy. Europace 2020. [DOI: 10.1093/europace/euaa162.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
BACKGROUND
The implantation of left ventricular (LV) leads for cardiac resynchronization therapy (CRT) and the management of lead-related complications can be challenging. The introduction of the quadripolar IS-4 LV lead may have facilitated the implantation procedure and may have reduced lead-related complications. Data of long-term follow-up (FU) comparing the IS-4 lead with the IS-1 LV lead are rare and conflicting.
PURPOSE
Comparison of lead-related complications and all-cause mortality between CRT patients who received an IS-4 or an IS-1 LV lead in the long-term FU.
METHODS
Adults with an indication for a CRT-Defibrillator or CRT-Pacemaker, a successful endovascular IS-4 or IS-1 LV lead implantation, and a minimal FU of three years were included in this retrospective study. The combined primary endpoint was freedom from lead-related complications defined as (i) occurrence of persisting high pacing threshold (>2.75V/0.4ms), (ii) unresolved phrenic nerve stimulation, (iii) LV lead dislodgement/disruption, (iv) the necessity of re-interventions affecting the LV lead, and (v) LV lead deactivation/explantation. Secondary endpoints were all singular complications and all-cause mortality.
RESULTS
Eligible for the study were 133 patients (IS-4 n = 66; IS-1 n = 67) with a mean FU of 4.03 ± 1.93 years. Baseline characteristics of both patient groups did not differ significantly. Freedom from lead-related complications was higher in patients with an IS-4 lead as compared to an IS-1 lead (Figure 1; 87.9% vs. 65.7%; p = 0.002). The secondary outcomes showed a higher rate of LV lead dislodgement/disruption (4.5% vs. 17.9%; p = 0.015) in the IS-1 patient group and more patients suffered from unresolved phrenic nerve stimulation with an IS-1 lead (3.0% vs. 13.4%; p = 0.029). LV lead deactivation/explantation during FU and LV lead-related re-interventions were fewer in case of an IS-4 lead (4.5% vs 22.4%; p = 0.003; 6.1% vs. 17.9%; p = 0.036, respectively). The rate of persisting high pacing thresholds and all-cause mortality did not differ (4.5% vs. 9.0%; p = 0.492; 22.7% vs 25.4%; p = 0.721, respectively).
CONCLUSION
The quadripolar IS-4 LV lead showed in this retrospective study a better long-term performance than the bipolar IS-1 lead.
Abstract Figure 1
Collapse
Affiliation(s)
- J Maurhofer
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - H Tanner
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - A Haeberlin
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - F Noti
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - J Seiler
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - S H Baldinger
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - L Roten
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - A Lam
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - B Asatryan
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - N Nozica
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - F Franzeck
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - T Kueffer
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - T Reichlin
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - H Servatius
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| |
Collapse
|
16
|
Burke C, Kohlbrenner R, Fidelman N, Heller M, Kolli K, Lam A, Lehrman E, Lokken R, Taylor A, Kumar V, Conrad M, Kohi M. 3:54 PM Abstract No. 105 Percutaneous transhepatic biliary drain placement for reduction of hyperbilirubinemia in malignant biliary obstruction: a bridge to chemotherapy or a bridge to nowhere? J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
17
|
Bennett R, Abi-Jaoudeh N, Rupasinghe M, Javan H, Lam A, Nelson K. Abstract No. 487 Role of time-resolved magnetic resonance angiography in appropriate diagnosis of patients with Klippel-Trenaunay syndrome. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
18
|
Bennett R, Abi-Jaoudeh N, Rupasinghe M, Javan H, Lam A, Nelson K. 3:54 PM Abstract No. 181 Technical and clinical success of endovenous ablation and sclerotherapy in Klippel-Trenaunay syndrome. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
19
|
Corfield B, Lam A. 21. Giant inflammatory polyposis in a patient with ulcerative colitis: A case report. Pathology 2020. [DOI: 10.1016/j.pathol.2020.01.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Wasserman M, Ouslander JG, Lam A, Wolk AG, Morley JE, von Preyss-Friedman S, Marco N, Nazir A, Haimowitz D, Bessey F. Editorial: Diagnostic Testing for SARS-Coronavirus-2 in the Nursing Facility: Recommendations of a Delphi Panel of Long-Term Care Clinicians. J Nutr Health Aging 2020; 24:538-443. [PMID: 32510102 PMCID: PMC7262162 DOI: 10.1007/s12603-020-1401-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Accepted: 05/26/2020] [Indexed: 01/12/2023]
Abstract
With the COVID-19 pandemic progressing, guidance on strategies to mitigate its devastating effects in nursing facilities (NFs) is critical to preventing additional tragic outcomes. Asymptomatic spread of COVID-19 from nursing facility staff and residents is a major accelerator of infection. Facility-wide point-prevalence testing is an emerging strategy in disease mitigation. Because time is not available to await the results of randomized controlled trials before implementing strategies in this high-risk setting, an expert Delphi panel composed of experienced long-term care medicine professionals has now met to provide testing guidance for SARS-Coronavirus-2 to NFs. After many email and telephone discussions, the panel responded to a questionnaire that included six different scenarios, based on varying availability of Polymerase Chain Reaction (RT-PCR) testing and personal protective equipment (PPE). The panel endorsed facility-wide testing of staff and residents without dissent when diagnostic RT-PCR was available. While the panel recognized the limitations of RT-PCR testing, it strongly recommended this testing for both staff and residents in NFs that were either COVID-19 naive or had limited outbreaks. There was also consensus on testing residents with atypical symptoms in a scenario of limited testing capability. The panel favored testing every 1 to 2 weeks if testing was readily available, reducing the frequency to every month as community prevalence declined or as the collection of additional data further informed clinical critical thinking and decision-making. The panel recognized that frequent testing would have consequences in terms of potential staff shortages due to quarantine after positive tests and increased PPE use. However, the panel felt that not testing would allow new clusters of infection to form. The resulting high mortality rate would outweigh the potential negative consequences of testing. The panel also recognized the pandemic as a rapidly evolving crisis, and that new science and increasing experience might require an updating of its recommendations. The panel hopes that its recommendations will be of value to the long-term care industry and to policy makers as we work together to manage through this challenging and stressful time.
Collapse
Affiliation(s)
- M Wasserman
- Michael Wasserman, MD, CMD, California Association of Long Term Care Medicine, 295 Mesa Ave., Newbury Park, CA 91320, , Ph. 720-412-5202
| | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Lam A, D'Rozario A, McKinnon A, Phillips C, Grunstein R, Naismith S. Delineating the role of osa on mild cognitive impairment profiles and memory recall performance in older adults at-risk of dementia. Sleep Med 2019. [DOI: 10.1016/j.sleep.2019.11.583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
22
|
Anwander M, Kueffer T, Branca M, Sweda R, Nozica N, Asatryan B, Lam A, Baldinger S, Haeberlin A, Seiler J, Servatius H, Tanner H, Reichlin T, Roten L, Noti F. P2855Unexpectedly high rate of lead failure of the Microport (formerly Sorin/Livanova) Beflex and Vega pacemaker electrodes: A single centre experience. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.1164] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Pacing leads remain the weak link of current pacemaker systems. Various differences in design and material exist among companies. Lead performance is mainly assessed via post-marketing studies of the manufacturing companies. Reliable independent reports are rare. We aimed to study the early and long-term performance of the Microport (formerly Sorin/Livanova) Beflex and Vega leads at our centre, for which a lead survival >99% at 3 years has been reported by the company.
Method
In this single centre, retrospective study we analysed the performance of all right ventricular Microport pacemaker leads implanted at our centre between January 2014 and January 2018. Only first pacemaker implants were considered. Lead failure was defined as any lead issue requiring reintervention during follow-up (dislocation, perforation, electrical abnormalities such as lead noise or excessively high thresholds).
Results
A total of 271 Microport right ventricular pacing leads were implanted (233 Beflex and 38 Vega leads). Mean patient age was 76±13.1 years (66% men). Dual chamber pacemakers were implanted in 162 patients (60%) and single chamber in 109 (40%). Mean threshold at implant was 0.6V/0.5ms (range 0.3–1.2V), mean R wave 13.2 mV (range 1.5–30mV) and mean impedance 816 Ohm (range 469–1639 Ohm). Patients without available follow-up information were excluded (N=18, 6.6%). The remaining 253 patients (93.4%) were analysed. Median follow-up was 1.26 years, IQR [25%=0.91 and 75%=2.24]. We observed a total of 25 lead failures (10%). Lead dislocation occurred in 2 cases (0.8%), lead perforation in 5 cases (2%), electrical abnormalities in 6 cases (2.4%) and excessively high threshold in 12 cases (4.8%; mean voltage 4V, range 2–7.5V; mean pulse width 0.75ms, range 0.35–1ms). Yearly incidence of lead failure per 100 leads was 6.1% (95%-CI [4.09–8.98] with a failure rate of 12.74% at 3 year in Kaplan-Meier analysis (Figure).
Figure 1
Conclusion
We found an unexpectedly high rate of lead failure of the Microport Beflex and Vega pacing leads at our centre. The two main reasons for premature lead failure were excessively high thresholds as well as electrical abnormalities during follow-up. Comparison of lead performance with other centres and against other leads are needed to further assess the magnitude of the problem.
Collapse
Affiliation(s)
- M Anwander
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - T Kueffer
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - M Branca
- University of Bern, Bern, Switzerland
| | - R Sweda
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - N Nozica
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - B Asatryan
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - A Lam
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - S Baldinger
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - A Haeberlin
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - J Seiler
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - H Servatius
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - H Tanner
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - T Reichlin
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - L Roten
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - F Noti
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| |
Collapse
|
23
|
Nozica N, Asatryan B, Noti F, Baldinger SH, Lam A, Haeberlin A, Servatius HS, Seiler J, Schwitz F, Tanner H, Wustmann KB, Delacretaz E, Schwerzmann M, Reichlin T, Roten L. P1007Efficacy and safety of atrial ablation procedures in patients with complete d-TGA and atrial switch at a Swiss tertiary center. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Patients with complete transposition of the great arteries (d-TGA) and atrial switch face a high lifetime risk of arrhythmias. Interventions in these patients are challenging because of their particular anatomy. Reports on ablation procedures in this patient population are scarce and missing for Switzerland.
Method
We retrospectively analyzed all ablation procedures performed in the above-mentioned population at a Swiss tertiary care center.
Results
Among 73 d-TGA pts. (71% male; N=37 Senning; N=36 Mustard) followed at our center, 17 ablations were performed in 11 pts. (15%; one ablation in 8 pts., two in 2 pts. and five in 1 patient). Median age at first ablation was 34 years (range 15–49 years). A total of 17 different intra-atrial reentry tachycardias (IART) and 3 AVNRT were targeted. Of the IART, 10 were cavotricuspid isthmus (CTI)-dependent and 7 were not. In two procedures (12%) only the systemic venous (SV) baffle was accessed for ablation. In 15 procedures (88%), ablation was performed within the pulmonary venous (PV) baffle. Access to the PV baffle was retrograde via the aorta in 6 cases (35%), via a baffle leak in 3 (18%) and via baffle puncture in 6 (35%). All procedures with retrograde approach to the PV baffle or with SV baffle only ablation were performed up to January 2012 and all remaining procedures afterwards. The 3 pts. requiring repeat procedures had retrograde or SV baffle approaches initially, and one additional ablation via baffle puncture was successful. The CTI was targeted in 10 pts. (91%) and ablation was finally successful in all with bidirectional block demonstrated in 8 pts. The coronary sinus was found to drain into the SV baffle in 5 pts. (46%) and useful for assessment of CTI block. The seven CTI-independent IART were scar-related micro-reentries. Ablation of all 3 AVNRTs was successful after one procedure without recurrence. Slow pathway ablation was performed in the SV baffle in two and in the PV baffle in one case (Figure). After a median follow-up of 7 months (range 2–186 months) 9 pts. are without recurrence and in 2 pts. rare self-limited arrhythmias still occur. No procedural complications occurred.
Conclusion
Arrhythmias in patients with complete d-TGA and atrial switch are mainly CTI-dependent IART or scar-related micro-reentries, and a few patients also have AVNRT. Ablation of these arrhythmias is safe and successful if PV baffle access is achieved via a baffle leak or baffle puncture.
Collapse
Affiliation(s)
- N Nozica
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - B Asatryan
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - F Noti
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - S H Baldinger
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - A Lam
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - A Haeberlin
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - H S Servatius
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - J Seiler
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - F Schwitz
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - H Tanner
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - K B Wustmann
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - E Delacretaz
- Clinique Cecil de recherche cardio-vasculaire, Lausanne, Switzerland
| | - M Schwerzmann
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - T Reichlin
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| | - L Roten
- Preventive Cardiology & Sports Medicine, Inselspital Bern, Bern, Switzerland
| |
Collapse
|
24
|
Sacher F, Roumegou P, Duchateau J, Derval N, Denis A, Pambrun T, Escande W, Takigawa M, Lam A, Andre C, Chauvel R, Hocini M, Haissaguerre M, Jais P, Cochet H. 5201Intra-cardiac thrombus in patients undergoing ventricular tachycardia ablation. a computed tomographic scan study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Embolic event is one of the complications of VT ablation. This may be due to the presence of intra-cardiac thrombus before ablation. However, there is no clear consensus on how to rule out thrombus before the procedure.
Objective
We sought to examine the prevalence and risk factors of intra-cardiac thrombus with cardiac computed tomographic (CT) scan in patients undergoing scar-related VT ablation.
Methods
In absence of contra-indication, all patients undergoing scar-related VT ablation at our institution underwent contrast-enhanced cardiac CT within one week before ablation. 324 consecutive patients (292 male, 59±16 yo) have been included in this study. The etiology was ischemic cardiomyopathy (CMP) (n=191), arrhythmogenic right ventricular CMP (ARVC) (n=37), congenital CMP (n=11) or other CMP (n=85). LVEF was <40% in 154 patients (48%).
Results
Intra-cardiac thrombus was diagnosed in 29 (9%) patients: in the left atrium (n=8), in the right atrium (n=1), in the left ventricle (n=15), in the right ventricle (n=3), in right and left atrium (n=1), and in left atrium and right ventricle (n=1). Moreover in 2, a bilateral pulmonary embolism was identified. The population with thrombus was older (65±12 vs 58±16 years, p=0,005), with more permanent atrial fibrillation (AF) (28% vs 8%; p=0.005). Patients with left ventricular (LV) aneurysm were at higher risk of thrombus 50% vs 3% (p<0.001). The average CHADSVASC score was similar for both groups (2,5 vs 2,1; p=0.179). After matching for age and sex, only ischemic CMP and LV aneurysm were risk factors for thrombus. Because of arrhythmic storm, ablation was performed by epicardial approach only, in 5 patients with intra-ventricular thrombus and by retroaortic approach only, in 2 patients with LAA thrombus. No embolic event occurred during these procedures.
Conclusion
CT scans help eliminating intra-cardiac thrombus before VT ablation procedure. A high proportion of thrombus (9%) was identified. Whereas LV thrombus should systematically be ruled out before scar related VT ablation, in patients with AF, a LAA thrombus should also be eliminated as well as RV thrombus in patients with ARVC.
Acknowledgement/Funding
ANR-10-IAHU-04
Collapse
Affiliation(s)
- F Sacher
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - P Roumegou
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - J Duchateau
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - N Derval
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - A Denis
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - T Pambrun
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - W Escande
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - M Takigawa
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - A Lam
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - C Andre
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - R Chauvel
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - M Hocini
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - M Haissaguerre
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - P Jais
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| | - H Cochet
- Bordeaux University Hospital and IHU LIRYC, Bordeaux-Pessac, France
| |
Collapse
|
25
|
Cabral M, Garçon G, Touré A, Diop C, Lam A, Fall M, Bouhsina S, Dewaele D, Cazier F, Tall-Dia A, Shirali P, Diouf A, Courcot D, Verdin A. Évaluation des atteintes néphroniques chez des adultes riverains d’une décharge à ciel ouvert. Toxicologie Analytique et Clinique 2019. [DOI: 10.1016/j.toxac.2019.03.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
26
|
Touré A, Cabral M, Dioum MD, Touré NN, Lam A, Ba F, Diop C, Diouf A, Malisch M, Fall M. Les polluants organiques persistants dans le lait maternel : évaluation des facteurs favorisant l’exposition au Sénégal. Toxicologie Analytique et Clinique 2019. [DOI: 10.1016/j.toxac.2019.03.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
27
|
Chambers D, Kumar A, Feng L, Hargreaves I, Lam A, Manzur A, Muntoni F, Sewry C, Poulton J, Phadke R. MITOCHONDRIAL DISEASES (Posters). Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
28
|
Mercure JF, Lam A, Billington S, Pollitt H. Integrated assessment modelling as a positive science: private passenger road transport policies to meet a climate target well below 2 ∘C. Clim Change 2018; 151:109-129. [PMID: 30930506 PMCID: PMC6404732 DOI: 10.1007/s10584-018-2262-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2017] [Accepted: 07/20/2018] [Indexed: 05/30/2023]
Abstract
Transport generates a large and growing component of global greenhouse gas emissions contributing to climate change. Effective transport emissions reduction policies are needed in order to reach a climate target well below 2 ∘C. Representations of technology evolution in current integrated assessment models (IAM) make use of systems optimisations that may not always provide sufficient insight on consumer response to realistic policy packages for extensive use in policy-making. Here, we introduce FTT: transport, an evolutionary technology diffusion simulation model for road transport technology, as an IAM sub-component, which features sufficiently realistic features of consumers and of existing technological trajectories that enables to simulate the impact of detailed climate policies in private passenger road transport. Integrated to the simulation-based macroeconometric IAM E3ME-FTT, a plausible scenario of transport decarbonisation is given, defined by a detailed transport policy package, that reaches sufficient emissions reductions to achieve the 2 ∘C target of the Paris Agreement.
Collapse
Affiliation(s)
- J.-F. Mercure
- Department of Environmental Science, Radboud University, PO Box 9010, 6500 GL Nijmegen, The Netherlands
- Cambridge Centre for Environment, Energy and Natural Resource Governance (C-EENRG), University of Cambridge, The David Attenborough Building, Pembroke Street, Cambridge, CB2 3QZ UK
- Cambridge Econometrics Ltd, Covent Garden, Cambridge, CB1 2HT UK
| | - A. Lam
- Cambridge Centre for Environment, Energy and Natural Resource Governance (C-EENRG), University of Cambridge, The David Attenborough Building, Pembroke Street, Cambridge, CB2 3QZ UK
- Department of Economics, Faculty of Social Sciences, Humanities and Social Science Building, University of Macau, E21, Avenida da Universidade, Taipa, Macau, China
| | - S. Billington
- Cambridge Econometrics Ltd, Covent Garden, Cambridge, CB1 2HT UK
| | - H. Pollitt
- Cambridge Econometrics Ltd, Covent Garden, Cambridge, CB1 2HT UK
| |
Collapse
|
29
|
Lam A, Cabral M, Touré A, Fall M, Diouf A, Chippaux J. Evaluation de la prise en charge des envenimations au Sénégal : étude clinique de l’Inoserp® Panafricain. Toxicologie Analytique et Clinique 2018. [DOI: 10.1016/j.toxac.2018.07.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
30
|
Lam A, Yoshida E, Bui K, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N. 3:00 PM Abstract No. 43 Comparison of ablation at high-volume centers with stereotactic body radiation therapy in early-stage primary non–small cell carcinoma: a National Cancer Database study. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
31
|
Lam A, Boenerjous SA, Lo Y, Abzug JM, Kurian J, Liszewski MC, Sanderson DE, Scholnick JM, Taragin BH, Gomez JA, Otsuka NY, Hanstein R. Diagnosing slipped capital femoral epiphysis amongst various medical specialists. J Child Orthop 2018; 12:160-166. [PMID: 29707055 PMCID: PMC5902750 DOI: 10.1302/1863-2548.12.170200] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
PURPOSE To evaluate sensitivity, specificity and accuracy of a radiographic slipped capital femoral epiphysis (SCFE)-diagnosis among medical specialists. METHODS Three paediatricians, three paediatric radiologists and three paediatric orthopaedic surgeons completed two rounds of a survey of anteroposterior and frog-leg lateral radiographs of patients with a diagnosis of SCFE (25), femoroacetabular impingement (four), Legg-Calvé-Perthes (11) or no hip pathology (ten). Intra- and interobserver agreement among specialties regarding the diagnosis of a SCFE were assessed using Cohen's kappa coefficient (κ). Diagnostic accuracy of SCFE relative to the benchmark, a combination of the radiographic diagnosis based on Klein's line, clinical symptoms and surgical treatment, was assessed computing sensitivity, specificity and accuracy. RESULTS Intraobserver agreement between the surveys was moderate among paediatricians (κ-range, 0.44 to 0.52), moderate to almost perfect among orthopaedic surgeons (κ-range, 0.79 to 0.88) and almost perfect among paediatric radiologists (κ-range, 0.83 to 1.00). Interobserver agreement for survey 1 and 2 was slight among paediatricians (mean κ, 0.19), substantial among orthopaedic surgeons (mean κ, 0.77) and almost perfect among paediatric radiologists (mean κ, 0.86). Sensitivity of SCFE-diagnosis was high among radiologists and orthopaedic surgeons (88% to 100% for both specialties), but lower for paediatricians (24% to 76%). Specificity was high among radiologists and orthopaedic surgeons (72% to 84%), however, variable among paediatricians (56% to 80%). Accuracy of a SCFE-diagnosis was highest in radiologists (84% to 92%), followed by orthopaedic surgeons (80% to 88%) and paediatricians (48% to 78%). CONCLUSION SCFE can be detected on radiographs by different medical specialties. Intra- and interobserver agreement, specificity, sensitivity and accuracy for radiographic SCFE-diagnosis amongst paediatric radiologists and orthopaedic surgeons are better than that of general paediatricians. LEVEL OF EVIDENCE II.
Collapse
Affiliation(s)
- A. Lam
- Albert Einstein College of Medicine, Bronx, New York, New York, USA
| | - S. A. Boenerjous
- Department of Orthopaedic Surgery, Montefiore Medical Center, Bronx, New York, New York, USA
| | - Y. Lo
- Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York, New York, USA
| | - J. M. Abzug
- University of Maryland School of Medicine, Baltimore, Maryland, USA
| | - J. Kurian
- Department of Radiology, Paediatric Radiology, Montefiore Medical Center, Bronx, New York, New York, USA
| | - M. C. Liszewski
- Department of Radiology, Paediatric Radiology, Montefiore Medical Center, Bronx, New York, New York, USA
| | - D. E. Sanderson
- Department of Paediatrics, General Paediatrics, Montefiore Medical Center, Bronx, New York, New York, USA
| | - J. M. Scholnick
- Department of Paediatrics, General Paediatrics, Montefiore Medical Center, Bronx, New York, New York, USA
| | - B H. Taragin
- Department of Radiology, Paediatric Radiology, Montefiore Medical Center, Bronx, New York, New York, USA
| | - J. A. Gomez
- Division of Paediatric Orthopaedics, Children’s Hospital at Montefiore Medical Center, Bronx, New York, New York, USA
| | - N. Y. Otsuka
- Division of Paediatric Orthopaedics, Children’s Hospital at Montefiore Medical Center, Bronx, New York, New York, USA
| | - R. Hanstein
- Division of Paediatric Orthopaedics, Children’s Hospital at Montefiore Medical Center, Bronx, New York, New York, USA, Correspondence should be sent to Regina Hanstein, 3400 Bainbridge Ave, MAP 6th floor, Bronx, NY 10467, United States. E-mail:
| |
Collapse
|
32
|
Lam A, Bui K, Padgett M, Mendoza E, Javan H, Sadeghi B, Gunasekaran S, Secrist M, Katrivesis J, Fernando D, Nelson K, Abi-Jaoudeh N. 3:18 PM Abstract No. 53 Changes in two-dimensional perfusion angiography before and after inferior vena cava filter retrieval. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
33
|
Lam A, Neergheen V, Chalasani A, Salih K, Pope S, Hargreaves I, Prunty H, Heales S. Biochemical markers of primary mitochondrial respiratory chain enzyme disorders. Neuromuscul Disord 2018. [DOI: 10.1016/s0960-8966(18)30384-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
34
|
Lam A. PO7 Primary endocrine therapy for breast cancer – A regional retrospective audit 2010 - 2015. Breast 2018. [DOI: 10.1016/j.breast.2018.02.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
35
|
Lam A, Wolf M, Kitamura T, Takigawa M, Martin C, Bourier F, Frontera A, Sacher F, Derval N, Denis A, Pambrun T, Duchateau J, Hochini M, Haissaguerre M, Jais P. 519Are recurrences of post MI VT due to substrate progression of insufficient index ablation? A 4 years FU study. Europace 2018. [DOI: 10.1093/europace/euy015.286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Lam
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - M Wolf
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - T Kitamura
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - M Takigawa
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - C Martin
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - F Bourier
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - A Frontera
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - F Sacher
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - N Derval
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - A Denis
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - T Pambrun
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - J Duchateau
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - M Hochini
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | | | - P Jais
- Hospital Haut Leveque, Bordeaux-Pessac, France
| |
Collapse
|
36
|
Servatius H, Pregaldini F, Haeberlin A, Seiler J, Roten L, Baldinger SH, Noti F, Medeiros-Domingo A, Elchinova E, Sweda R, Lam A, Fuhrer J, Tanner H. P855Symptom assessment before and after catheter ablation of atrial fibrillation using the modified EHRA score. Europace 2018. [DOI: 10.1093/europace/euy015.458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- H Servatius
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - F Pregaldini
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - A Haeberlin
- University of Bern, ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland, Bern, Switzerland
| | - J Seiler
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - L Roten
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - S H Baldinger
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - F Noti
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - A Medeiros-Domingo
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - E Elchinova
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - R Sweda
- University of Bern, ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland, Bern, Switzerland
| | - A Lam
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - J Fuhrer
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - H Tanner
- University of Bern, Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland
| |
Collapse
|
37
|
Koitka K, Shiino K, Kelly N, Lam A, Platts D, Scalia G, Chan J. Strain Assessment of Left Atrial Function in Biopsy-Proven Cardiac Amyloidosis. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
38
|
Abstract
Abstract
The evaluation of uric acid concentrations in the blood of snakes is a crucial tool in the diagnosis of gout and renal disease; both prevalent diseases in captive reptiles. However, without an understanding of the physiological fluctuations in uric acid levels and the absence of distinction that makes pathological changes, biochemical parameters are devalued. This study focuses on investigating the relationship between feeding rate and plasma-uric acid concentrations of snakes. The aim of this investigation is to facilitate a better understanding of the feed-induced changes that occur, and to render the analysis of this biochemical parameter as a more potent diagnostic tool. A total of 10 snakes were used in the study and the basal concentration of uric acid was established prior to feeding via blood biochemical analysis. The snakes were then fed rats and successive postprandial blood samples were taken for the monitoring of uric acid levels. The results demonstrated that feeding led to substantial elevations in the uric acid values, whereby postprandial concentrations were significantly elevated for up to 5 days after feeding. The postprandial elevations in uric acid documented in these snakes were of similar levels reported in snakes afflicted with gout or renal disease. The results demonstrated the significant changes that occur to uric acid levels after feeding, and highlights the resemblance between postprandial increases in uric acid and concentrations reported in snakes suffering from renal disease or gout. To avoid a misdiagnosis and to distinguish transient postprandial hyperuricemia from pathological elevations, collecting sufficient anamnestic data on time since last feeding in performing repeated sampling after one week period of fasting is suggested.
Collapse
Affiliation(s)
- A. Lam
- Department of Epizootology and Parasitology, University of Veterinary Medicine and Pharmacy, Komenského 73, 041 81 Kosice , Slovakia
| | - M. Halán
- Department of Epizootology and Parasitology, University of Veterinary Medicine and Pharmacy, Komenského 73, 041 81 Kosice , Slovakia
| |
Collapse
|
39
|
McEwen S, Dunphy C, Norman Rios J, Davis A, Jones J, Lam A, Poon I, Martino R, Ringash J. Development and pre-testing of a rehabilitation planning consultation for head-and-neck cancer. ACTA ACUST UNITED AC 2017; 24:153-160. [PMID: 28680274 DOI: 10.3747/co.24.3529] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND In contrast with other major chronic conditions such as heart disease and stroke, cancer care does not routinely integrate evidence-based rehabilitation services within the standard continuum. The objectives of the present project were to develop a rehabilitation planning consultation (rpc) for survivors of head-and-neck (hn) cancer, to test its feasibility, and to make refinements. METHODS Using intervention mapping, the rpc-alpha was developed by examining potential theoretical methods and practical applications relative to the program objectives. During feasibility testing, a single case series was conducted with survivors of hn cancer who had completed their cancer treatment within the preceding 11 months; iterative refinements were made after each case. RESULTS The rpc-alpha was led by a rehabilitation professional and was based on self-management principles. The initial consultation included instruction in a global cognitive strategy, goal-setting, introduction to available resources, action planning, and coping planning. A follow-up consultation was conducted a few weeks later. Of 9 participants recruited, 5 completed post-intervention assessments. Participants reported that the rpc helped them to make rehabilitation plans. CONCLUSIONS The rpc was feasible to use and satisfactory to a small group of hn cancer survivors. A pilot test of the refined version is in process.
Collapse
Affiliation(s)
- S McEwen
- Sunnybrook Research Institute, St. John's Rehab Research Program, Toronto.,University of Toronto, Toronto
| | - C Dunphy
- University Health Network, Princess Margaret Cancer Centre, Toronto
| | - J Norman Rios
- Sunnybrook Research Institute, St. John's Rehab Research Program, Toronto
| | - A Davis
- University of Toronto, Toronto.,University Health Network, Toronto Western Research Institute, Toronto
| | - J Jones
- University of Toronto, Toronto.,University Health Network, Princess Margaret Cancer Centre, Toronto
| | - A Lam
- University Health Network, Princess Margaret Cancer Centre, Toronto.,The University of Western Ontario, London; and
| | - I Poon
- University of Toronto, Toronto.,Odette Cancer Centre, Sunnybrook Hospital, Toronto, ON
| | | | - J Ringash
- University of Toronto, Toronto.,University Health Network, Princess Margaret Cancer Centre, Toronto
| |
Collapse
|
40
|
Goulouti E, Lam A, Haeberlin A, Sweda R, Medeiros-Domingo A, Noti F, Seiler J, Baldinger S, Servatius H, Fuhrer J, Tanner H, Roten L. P457Variability of premature ventricular contractions and presence of nonsustained ventricular tachycardias. Europace 2017. [DOI: 10.1093/ehjci/eux141.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
41
|
Lam A, Goulouti E, Haeberlin A, Sweda R, Medeiros-Domingo A, Seiler J, Baldinger S, Noti F, Servatius H, Fuhrer J, Tanner H, Roten L. P456Variability of premature atrial contraction count and presence of nonsustained atrial tachycardias. Europace 2017. [DOI: 10.1093/ehjci/eux141.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Asatryan B, Schaller A, Seiler J, Lam A, Haeberlin A, Servatius H, Baldinger S, Goulouti E, Fuhrer J, Tanner H, Roten L, Noti F, Wilhelm M, Medeiros-Domingo A. P1598Genetic testing yield in survivors of unexplained cardiac arrest. Europace 2017. [DOI: 10.1093/ehjci/eux158.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
43
|
Sweda R, Haeberlin A, Servatius H, Seiler J, Noti F, Medeiros-Domingo A, Baldinger S, Lam A, Goulouti E, Fuhrer J, Roten L, Tanner H. P1431Left atrial access in atrial fibrillation: patent foramen ovale versus transseptal puncture. Europace 2017. [DOI: 10.1093/ehjci/eux158.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Lam A, Sivalingam J, Chen A, Reuveny S, Loh Y, Oh S. Microcarrier-based platforms for derivation, expansion and differentiation of induced pluripotent stem cells. Cytotherapy 2017. [DOI: 10.1016/j.jcyt.2017.02.356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Solberg A, Javan H, Sadeghi B, Hernandez-Rangel E, Kuoy E, Bui K, Lam A, Knipping S, Nelson K, Fernando D, Abi-Jaoudeh N. Accuracy of Virtual Parenchymal Perfusion software in predicting treatment volumes during intra-arterial therapies. J Vasc Interv Radiol 2017. [DOI: 10.1016/j.jvir.2016.12.1113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
46
|
Vosgha H, Salajegheh A, Lam A. Taking advantage of an imperfect match: Inhibition of invasion, metastasis and angiogenesis through miR-205. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32692-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
To V, Lam A, Hengrasmee P. Exploring the Benefits of Robotic Surgery in the Management of Severe Endometriosis. J Minim Invasive Gynecol 2016. [DOI: 10.1016/j.jmig.2016.08.355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
48
|
To V, Lam A, Hengrasmee P. Robotic Application and Special Surgical Techniques to Removal Multiple Fibroids in a Culturally Challenging Context. J Minim Invasive Gynecol 2016. [DOI: 10.1016/j.jmig.2016.08.349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
49
|
Lam A, Almotrafi TA, Mangot M. Laparoscopic Excision of Extensive Endometriosis Infiltrating Ureter, Bladder, Recto-Sgimoid, Pelvic Sidewall and Repair of Injury to the External Iliac and Aberrant Obturator Vein. J Minim Invasive Gynecol 2016; 22:S149. [PMID: 27678834 DOI: 10.1016/j.jmig.2015.08.540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- A Lam
- Gynecology/Minimal Invasive Surgery, Centre for Advanced Reproductive Endosurgery, Sydney, NSW, Australia
| | - T A Almotrafi
- Gynecology/Minimal Invasive Surgery, Centre for Advanced Reproductive Endosurgery, Sydney, NSW, Australia
| | - M Mangot
- Gynecology/Minimal Invasive Surgery, Centre for Advanced Reproductive Endosurgery, Sydney, NSW, Australia
| |
Collapse
|
50
|
Hengrasmee P, Lam A. 10 Practical Steps in Laparoscopic Sacrohysteropexy. J Minim Invasive Gynecol 2016; 22:S146. [PMID: 27678816 DOI: 10.1016/j.jmig.2015.08.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- P Hengrasmee
- Centre for Advanced Reproductive Endosurgery, St. Leonard's, New South Wales, Australia
| | - A Lam
- Centre for Advanced Reproductive Endosurgery, St. Leonard's, New South Wales, Australia
| |
Collapse
|